The Intravenous Ibuprofen Market Is Predicted To Reach USD 14.23 Billion With A CAGR Of 20.0% According To Market Data Forecast Report.

The Intravenous Ibuprofen Market Is Predicted To Reach USD 14.23 Billion With A CAGR Of 20.0% According To Market Data Forecast Report.

ID: 6741 | March 2018 | Region: Global


The Intravenous Ibuprofen Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Intravenous Ibuprofen Market is estimated to be USD 5.72 billion in 2017 and predicted to rise to USD 14.23 billion by 2022 with a CAGR of 20.0%. The market is segmented by age group (adults and pediatrics) , by indication ( fever and pain/inflammatory) . Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Due to its faster onset of action and fast results, the market is expected to grow at a rapid rate during the forecast period. As it has been approved for pediatric use, the market is further expected to propel. Due to increased incidence of cardiovascular diseases, cancer and fever coupled with shifting trend to non-opoid drugs is further driving the market growth. However, the side effects associated with the use of ibuprofen and the lengthy approval processes are hampering the market growth.

The market for Intravenous Ibuprofen is broadly categorized into age group and indication. By age group the market is divided into adults and pediatrics. Adults are the major consumer base for intravenous ibuprofen. The pediatric segment is expected to grow at a substantial rate. By indication the market is further classified into fever and pain/inflammatory. Fever is projected to be the fastest growing segment.

On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Intravenous Ibuprofen market was dominated by North America. Asia Pacific is expected to grow at a high CAGR.

Some of the major companies dominating the market, by their products and services include Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt Ltd., Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd., PT. Soho Industri Pharmasi, and Laboratorios Valmorca, C.A.

Browse through the full report at “https://www.marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/” and checkout our recent reports in the Pharmaceuticals category at “https://www.marketdataforecast.com/subcategory/pharmaceuticals-1/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.